OTF
BIIB icon

Opus Trading Fund’s Biogen BIIB Stock Holding History

Opus Trading Fund’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$441K Buy
+2,050
New +$438K 0.85% 22

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Opus Trading Fund's BIIB Position: Q2 2013 in Review

Opus Trading Fund opened a new position in Biogen (BIIB) in Q2 2013: 2,050 shares worth $441K. The stake represents 0.85% of the portfolio and ranks #22 among its holdings.

646 funds tracked by Wall St. Rank hold BIIB as of Q2 2013.

  • Opus Trading Fund held 2,050 shares of Biogen worth $441K as of Q2 2013.
  • Biogen was a new Opus Trading Fund position in Q2 2013.
  • Biogen made up 0.85% of Opus Trading Fund's portfolio in Q2 2013, its #22 holding.
  • 646 funds tracked by Wall St. Rank held Biogen as of Q2 2013.

Based on Opus Trading Fund's 13F filing for Q2 2013, filed 5 Aug 2013.